116 related articles for article (PubMed ID: 19136893)
1. Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes.
Vantyghem MC; Marcelli-Tourvieille S; Fermon C; Duhamel A; Raverdy V; Arnalsteen L; Kerr-Conte J; Noel C; Fontaine P; Pattou F
Transplantation; 2009 Jan; 87(1):66-71. PubMed ID: 19136893
[TBL] [Abstract][Full Text] [Related]
2. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
[TBL] [Abstract][Full Text] [Related]
3. Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations.
Berney T; Bucher P; Mathe Z; Andres A; Bosco D; Mage R; Toso C; Oberholzer J; Becker C; Philippe J; Bühler L; Morel P
Transplant Proc; 2004 May; 36(4):1121-2. PubMed ID: 15194390
[TBL] [Abstract][Full Text] [Related]
4. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
[TBL] [Abstract][Full Text] [Related]
5. Improved metabolic control preserved beta-cell function two years after diagnosis of insulin-dependent diabetes mellitus.
Montanya E; Fernandez-Castañer M; Soler J
Diabetes Metab; 1997 Sep; 23(4):314-9. PubMed ID: 9342545
[TBL] [Abstract][Full Text] [Related]
6. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.
Biesenbach G; Königsrainer A; Gross C; Margreiter R
Transpl Int; 2005 Sep; 18(9):1054-60. PubMed ID: 16101726
[TBL] [Abstract][Full Text] [Related]
7. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
8. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring.
Kessler L; Passemard R; Oberholzer J; Benhamou PY; Bucher P; Toso C; Meyer P; Penfornis A; Badet L; Wolf P; Colin C; Morel P; Pinget M;
Diabetes Care; 2002 Dec; 25(12):2256-62. PubMed ID: 12453970
[TBL] [Abstract][Full Text] [Related]
9. Glycemia, Hypoglycemia, and Costs of Simultaneous Islet-Kidney or Islet After Kidney Transplantation Versus Intensive Insulin Therapy and Waiting List for Islet Transplantation.
Gerber PA; Locher R; Zuellig RA; Tschopp O; Ajdler-Schaeffler E; Kron P; Oberkofler C; Brändle M; Spinas GA; Lehmann R
Transplantation; 2015 Oct; 99(10):2174-80. PubMed ID: 25905979
[TBL] [Abstract][Full Text] [Related]
10. Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation.
Fiorina P; Folli F; Maffi P; Placidi C; Venturini M; Finzi G; Bertuzzi F; Davalli A; D'Angelo A; Socci C; Gremizzi C; Orsenigo E; La Rosa S; Ponzoni M; Cardillo M; Scalamogna M; Del Maschio A; Capella C; Di Carlo V; Secchi A
Transplantation; 2003 Apr; 75(8):1296-301. PubMed ID: 12717219
[TBL] [Abstract][Full Text] [Related]
11. Results from the inaugural year of the Collaborative Islet Transplant Registry.
Close NC; Hering BJ; Eggerman TL
Transplant Proc; 2005 Mar; 37(2):1305-8. PubMed ID: 15848704
[TBL] [Abstract][Full Text] [Related]
12. Histologic graft assessment after clinical islet transplantation.
Toso C; Isse K; Demetris AJ; Dinyari P; Koh A; Imes S; Kin T; Emamaullee J; Senior P; Shapiro AM
Transplantation; 2009 Dec; 88(11):1286-93. PubMed ID: 19996928
[TBL] [Abstract][Full Text] [Related]
13. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
[TBL] [Abstract][Full Text] [Related]
14. C-peptide and glucose values in the peritransplant period after intraportal islet infusions in type 1 diabetes.
Faradji RN; Monroy K; Cure P; Froud T; Baidal D; Pileggi A; Messinger S; Ricordi C; Alejandro R
Transplant Proc; 2005 Oct; 37(8):3433-4. PubMed ID: 16298619
[TBL] [Abstract][Full Text] [Related]
15. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Szypowska A; Lipka M; Błazik M; Golicka D; Groele L; Pańkowska E
Acta Paediatr; 2009 Mar; 98(3):523-6. PubMed ID: 19046348
[TBL] [Abstract][Full Text] [Related]
17. Adverse events in clinical islet transplantation: one institutional experience.
Takita M; Matsumoto S; Noguchi H; Shimoda M; Ikemoto T; Chujo D; Tamura Y; Olsen GS; Naziruddin B; Purcell K; Onaca N; Levy MF
Cell Transplant; 2012; 21(2-3):547-51. PubMed ID: 22793063
[TBL] [Abstract][Full Text] [Related]
18. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
Hermansen K; Dornhorst A; Sreenan S
Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
[TBL] [Abstract][Full Text] [Related]
19. A patient with severe, recurrent hypoglycemia and glycemic lability who underwent islet transplantation.
Ryan EA; Shapiro AJ
Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):349-53; quiz 354. PubMed ID: 16932312
[TBL] [Abstract][Full Text] [Related]
20. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
Valensi P; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Wenying Y;
Int J Clin Pract; 2009 Mar; 63(3):522-31. PubMed ID: 19187170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
